Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05411367 · ClinicalTrials.gov registry record · Phase 3

A Study for Evaluation of the Efficacy and Safety of SI-614 Ophthalmic Solution in Patient With Dry Eye

A Phase 3 study of Dry Eye Disease, sponsored by Seikagaku Corporation.

Completed
Registry status
Phase 3
Development phase
232
Enrollment target
6
Study locations

NCT05411367 is a Phase 3 study of Dry Eye Disease that has completed, run by Seikagaku Corporation. The registered enrollment target is 232 participants, roughly in line with the 248-participant average among 33 other Dry Eye Disease trials with a reported enrollment target. The trial reports 6 study locations across 6 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05411367, a Phase 3 study of Dry Eye Disease, has completed, sponsored by Seikagaku Corporation.

COMPLETED
Registry status
Phase 3
Development phase
232 participants
Enrollment target
6
Study locations

Study Summary

The purpose of this study is to evaluate the efficacy and safety of SI-614 ophthalmic solution compared with placebo in patients with dry eye

Conditions Studied

Dry Eye Disease

Interventions

  • DRUG Placebo
  • DRUG SI-614

Study Locations (6)

California

  • Eye Research Foundation - Newport Beach

Kentucky

  • Butchertown Clinical Trials - Louisville

Massachusetts

  • Andover Eye Associates, Inc. - Andover

Nevada

  • Center for Sight - Henderson

North Carolina

  • CORE Inc, Vita Eye Clinic - Shelby

Tennessee

  • Total Eye Care, PA - Memphis

Trial Details

FieldValue
Enrollment Target 232 participants
Start Date 2022-07-28
Est. Completion 2023-04-27
Phase Phase 3

Sponsor

Seikagaku Corporation

12 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05411367

The ClinicalTrials.gov registry entry for NCT05411367 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 232 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 248-participant average among 33 other Dry Eye Disease trials with a reported enrollment target. The listed sponsor is Seikagaku Corporation, which has 12 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Dry Eye Disease appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT05411367 reports 6 study locations spanning 6 distinct geographic areas - top geographies include California, Kentucky, Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05411367 about?

NCT05411367 is a clinical study titled "A Study for Evaluation of the Efficacy and Safety of SI-614 Ophthalmic Solution in Patient With Dry Eye". The purpose of this study is to evaluate the efficacy and safety of SI-614 ophthalmic solution compared with placebo in patients with dry eye

What is the current status of trial NCT05411367?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 232 participants. The study started on 2022-07-28. Estimated completion is 2023-04-27.

What conditions does trial NCT05411367 study?

This clinical trial studies the following conditions: Dry Eye Disease.

What interventions are being tested in trial NCT05411367?

The interventions under investigation include: Placebo (DRUG), SI-614 (DRUG).

Who is sponsoring clinical trial NCT05411367?

This trial is sponsored by Seikagaku Corporation, which has 12 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05411367 being conducted?

This trial has 6 study locations across California, Kentucky, Massachusetts, Nevada, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Dry Eye Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Dry Eye Disease

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.